Citadel Advisors’s Edgewell Personal Care EPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,800
Closed -$321K 13281
2025
Q4
$321K Buy
+18,800
New +$348K ﹤0.01% 9986
2025
Q2
Sell
-4,800
Closed -$150K 13184
2025
Q1
$150K Sell
4,800
-700
-13% -$22K ﹤0.01% 10878
2024
Q4
$185K Sell
5,500
-2,000
-27% -$70.6K ﹤0.01% 10575
2024
Q3
$273K Buy
7,500
+100
+1% +$3.86K ﹤0.01% 9526
2024
Q2
$297K Buy
7,400
+1,200
+19% +$46K ﹤0.01% 9154
2024
Q1
$240K Sell
6,200
-3,000
-33% -$113K ﹤0.01% 9940
2023
Q4
$337K Sell
9,200
-5,500
-37% -$195K ﹤0.01% 8933
2023
Q3
$543K Sell
14,700
-4,400
-23% -$170K ﹤0.01% 7875
2023
Q2
$789K Buy
19,100
+800
+4% +$34.2K ﹤0.01% 6955
2023
Q1
$776K Buy
18,300
+8,700
+91% +$365K ﹤0.01% 7347
2022
Q4
$370K Buy
9,600
+1,400
+17% +$55.6K ﹤0.01% 8873
2022
Q3
$307K Sell
8,200
-1,500
-15% -$58.5K ﹤0.01% 9519
2022
Q2
$335K Buy
9,700
+1,000
+11% +$36K ﹤0.01% 9566
2022
Q1
$319K Sell
8,700
-6,300
-42% -$257K ﹤0.01% 10460
2021
Q4
$686K Buy
+15,000
New +$605K ﹤0.01% 8896
2021
Q3
Sell
-18,100
Closed -$795K 13979
2021
Q2
$795K Sell
18,100
-19,300
-52% -$818K ﹤0.01% 8960
2021
Q1
$1.48M Buy
37,400
+700
+2% +$24.2K ﹤0.01% 7140
2020
Q4
$1.27M Sell
36,700
-7,000
-16% -$227K ﹤0.01% 6286
2020
Q3
$1.22M Sell
43,700
-11,600
-21% -$344K ﹤0.01% 5674
2020
Q2
$1.72M Buy
55,300
+2,000
+4% +$56K ﹤0.01% 4837
2020
Q1
$1.28M Buy
53,300
+11,400
+27% +$341K ﹤0.01% 4894
2019
Q4
$1.3M Buy
41,900
+10,800
+35% +$349K ﹤0.01% 5126
2019
Q3
$1.01M Buy
31,100
+18,500
+147% +$552K ﹤0.01% 5577
2019
Q2
$340K Sell
12,600
-1,300
-9% -$46.4K ﹤0.01% 7397
2019
Q1
$610K Sell
13,900
-93,100
-87% -$3.88M ﹤0.01% 6452
2018
Q4
$4M Sell
107,000
-8,200
-7% -$358K ﹤0.01% 3108
2018
Q3
$5.33M Buy
115,200
+94,800
+465% +$5.01M ﹤0.01% 2918
2018
Q2
$1.03M Buy
+20,400
New +$937K ﹤0.01% 5163
2018
Q1
Sell
-4,700
Closed -$279K 8389
2017
Q4
$279K Sell
4,700
-800
-15% -$50.3K ﹤0.01% 6577
2017
Q3
$400K Buy
5,500
+500
+10% +$36.9K ﹤0.01% 5635
2017
Q2
$380K Sell
5,000
-5,900
-54% -$434K ﹤0.01% 5528
2017
Q1
$797K Buy
10,900
+7,500
+221% +$571K ﹤0.01% 4335
2016
Q4
$248K Sell
3,400
-9,400
-73% -$727K ﹤0.01% 5953
2016
Q3
$1.02M Buy
12,800
+6,100
+91% +$492K ﹤0.01% 3812
2016
Q2
$566K Buy
6,700
+2,300
+52% +$186K ﹤0.01% 4316
2016
Q1
$354K Sell
4,400
-700
-14% -$53.7K ﹤0.01% 4880
2015
Q4
$400K Sell
5,100
-1,600
-24% -$130K ﹤0.01% 4780
2015
Q3
$547K Sell
6,700
-31,000
-82% -$2.81M ﹤0.01% 4681
2015
Q2
$4.96M Buy
37,700
+20,568
+120% +$2.12M ﹤0.01% 2079
2015
Q1
$1.75M Buy
17,132
+11,736
+217% +$1.16M ﹤0.01% 3232
2014
Q4
$514K Sell
5,396
-8,094
-60% -$744K ﹤0.01% 4689
2014
Q3
$1.23M Sell
13,490
-7,150
-35% -$640K ﹤0.01% 3450
2014
Q2
$1.87M Buy
20,640
+4,587
+29% +$377K ﹤0.01% 2785
2014
Q1
$1.2M Sell
16,053
-2,698
-14% -$197K ﹤0.01% 3211
2013
Q4
$1.5M Buy
18,751
+7,959
+74% +$606K ﹤0.01% 2816
2013
Q3
$729K Sell
10,792
-2,833
-21% -$209K ﹤0.01% 3415
2013
Q2
$1.01M Buy
+13,625
New +$991K ﹤0.01% 3173

Other funds holding EPC

Citadel Advisors's EPC Position: Q1 2026 in Review

Citadel Advisors reduced its Edgewell Personal Care (EPC) stake by 92% in Q1 2026, selling an estimated $3.7M and leaving 16,080 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #10161.

Citadel Advisors first reported a position in EPC in Q2 2013 and has held it in 47 quarters since. The position peaked at $152M in Q4 2014. 222 funds tracked by Wall St. Rank hold EPC as of Q1 2026.

  • Citadel Advisors held 16,080 shares of Edgewell Personal Care worth $343K as of Q1 2026.
  • Citadel Advisors sold 183,624 Edgewell Personal Care shares in Q1 2026, an estimated $3.7M.
  • Edgewell Personal Care made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10161 holding.
  • Citadel Advisors first reported a position in Edgewell Personal Care in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Edgewell Personal Care position peaked at $152M in Q4 2014.
  • 222 funds tracked by Wall St. Rank held Edgewell Personal Care as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.